Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose IL-2 to Expand Endogenous Regulatory T-cells and Achieve Tolerance in Liver Transplantation

NCT02949492 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT02949492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02949492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose IL-2 to Expand Endogenous Regulatory T-cells and Achieve Tolerance in Liver Transplantation
Lead sponsor
King's College London
Phase
Phase 4
Overall status
Terminated
Start date
December 12, 2017
Completion date
January 31, 2019
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver diseases, transplantation